Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Amryt Pharma
Pharmaceutical Preparation ManufacturingIrelandNASDAQ: AMYT
Last verified 25 days agoamrytpharma.com
Amryt Pharma, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Ireland (IE) and operates across various regions, focusing on innovative treatments for rare and complex diseases. Founded in 2015, the company has rapidly established itself as a key provider of specialised therapies, particularly in dermatology and metabolic disorders.
Amryt Pharma's core products, including the unique topical treatment for epidermolysis bullosa, highlight its commitment to addressing unmet medical needs. The company has achieved significant milestones, including successful product launches and strategic partnerships, positioning itself as a trusted name in the pharmaceutical landscape. With a focus on patient-centric solutions, Amryt Pharma continues to make strides in improving the quality of life for patients worldwide.
63
DitchCarbon score
+21 vs industry average
Amryt Pharma’s score of 63 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Amryt Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2021
20202021
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Amryt Pharma's reported carbon emissions
Amryt Pharma, a pharmaceutical preparation manufacturer headquartered in Ireland, reported total carbon emissions of approximately 368,480 kg CO2e in 2021. This represents a decrease from their 2020 emissions, which were approximately 441,380 kg CO2e. The available data for both years does not specify emissions by Scope 1, Scope 2, or Scope 3, and indicates missing data points for Scope 1 total, Scope 2 total, and Scope 3 purchased goods and services.
While Amryt Pharma's specific climate commitments are not detailed in the provided data, their emissions data is cascaded from their parent company, Amryt Pharma plc, with SBTi and other initiatives cascaded from Chiesi Farmaceutici S.p.A.
Assessing Amryt Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Amryt Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Amryt Pharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Amryt Pharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Chiesi Farmaceutici S.p.A.2030 targetSee details
Active
Carbon Disclosure Project
Inherited from Chiesi Farmaceutici S.p.A.Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
Inherited from Chiesi Farmaceutici S.p.A.See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Amryt Pharma25 days ago
63
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more